Lausanne, Vaud, Switzerland
Innovative, dynamic, multi-lingual C-Suite Officer with strong leadership skills and proven performance excellence in P&L management, commercial execution, strategic planning, board management, investor and stakeholder partnerships, international and domestic markets. I have more than 25 years of experiences in building global and regional top-performing teams in medical device, life sciences, and healthcare industries in over 90 countries. Professional expertise includes: Financial Management • Building Top-Performing Teams • Internal and External Communication • Mergers & Acquisitions • Strong Strategic Vision • Change Management • Operational Simplification and Innovation • Portfolio Optimisation and New Portfolio Expansion • Channel and Market Management • Short and Long Term Strategic Plans • Diversity and Inclusion Specialties: Global Cultural Expertise, Inspirational Leadership, Focused Commercial Execution, Business turnaround Expertise, Business Agility, Vast experiences in leading EMEA, APAC and LATAM regions 上級経営幹部 -- グローバル通商 25年以上専門分野に身を置く精力的な経営者で、複数のプロダクトポートフォリオにわたって組織構造や人材獲得などの商業上・財政上の優れた戦略を設計し、国内および国際市場を創出している。90以上の市場を牽引し、持続可能な営業や利益向上に取り組み、拡大し、改善した。それぞれの市場で標的とすべきニッチを見極めて最大化することに長けており、効果的な市場キャンペーンへと導いて利益増加をもたらした。一貫して財政目標を上回り、出資者の期待に応えた。 専門分野は以下の通り-- 事業開発および拡大 変革管理 文化的意識 リスク管理および危機管理 戦略設計および分析 会計/損益管理 人材開発 コマーシャルエクセレンス 出資者管理 私は日本に家族の関係の人脈があり、2017年以来、日本の商業経営（処方薬、医療機器および消費者）を指揮してきました。
Responsible for Market Development, Business Development, Business Strategy, Commercial Strategy, International Business Expansion, Distributor Management, Strategic Planing, Coaching, Board Management, Investor Partnership • Build the Global Commercial & Marketing organizations, design Go to Market models to enter New Markets. • Supervise & lead the Company’s Strategic Plans elaboration. • Guide the Company’s future Product Portfolio (Portfolio Optimisation) at Global Marketing and R&D levels. • Define the strategy and co-lead strategic Merger & Acquisitions with PE and VC companies for investments. • Build and supervise the Company’s Talent Mapping. • Lead Right Sizing organizational changes for improving efficiency and sustainable sales & profits.
• Built the Company's International Markets Zone / Division • Managed 32 affiliates and more than 60 distributors in >90 markets • Grew product portfolios in Pharma, Medical Device and Consumer • Led & trained teams, ensuring continuous performance improvement • Grew markets in China, Japan, Brazil, Europe, Russia & Middle East • Restructured the Brazilian organization, boosting OG and EBITA • Redesigned the go-to market model for China, increasing CAGR • Customized the product portfolio for EU markets, delivering growth • Accelerated the development of 25 talents to serve in critical roles • Developed strategy for a strategic M&A review and profitable sale
• Managed commercial, functional organizations within Galderma • Led 3 franchises in 20 affiliates and 30 distributors in 60 markets • Reallocated resources on selected brands to improve performance • Launched 2 strategic brands, achieving market leadership by Year 2 • Improved marketing to outpace competitors in all major brands • Applied customer insights & market models to build a MENA cluster • Redesigned Latin American market practices for higher growth • Embedded strict financial discipline to improve operational results
• Led 3 franchises plus support functions in 12 entities • Managed 50 distributors in more than 70 markets • Re-structured key European markets plus Africa and ME • Oversaw a project to invest in African markets via local HCPs • Led market promotions with in-market & in-European clubs • Built strong Key Opinion Leader relations via think-tanks • Key player in the strategic merger of Ciba into Alcon • Successfully orchestrated the post-merger organizations • Managed post-merger appointments of market leaders • Led Corporate Humanitarian Activities in ME, Africa & CIS
• Directed 3 business franchises within 6 affiliates • Managed >30 distributors in over 60 EMEA markets • Built an ME Cluster under a Dubai Management Center • Improved diversity in the ME to 50% female leaders • Achieved 28% OG growth and over 400 bps EBITA • Eliminated bad debts by recovering CHF multimillions • Restructured the Turkish affiliate to meet HCP needs • Won market leadership in Prescription & Medical Devices
• Held a range of marketing, commercial and leadership roles at Alcon in Turkey, Switzerland and the USA 1990-2008